Trial intelligence / Profile preview

Asmanex Twisthaler in Mild/Moderate Persistent Asthma

NCT00442351Phase 4Terminated

Sponsor
Organon & Co.
Start
Sep 2006
Primary completion
Apr 2007
Modality
Orthosteric Ligands
01

Overview

Phase 4, randomised, double-blind trial in asthma comparing Asmanex Twisthaler with Placebo (2 arms). Primary endpoint: Forced Expiratory Volume in 1 Second at 12 weeks. Started Sep 2006; status: terminated.

02

Drugs

mometasone
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00442351.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00442351.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call